Maxmarvil
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background Bisphosphonate (BP) is an effective drug for the prevention and treatment of osteoporosis. However, gastrointestinal…
Background The purpose of this prospective, open-label, observational study was to assess the fracture preventing effect of…
Background/Aims This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before…
Alendronate is one of the most potent anti-osteoporotic agents for postmenopausal osteoporosis. However, high doses of…
Background Combined therapy with alendronate and calcitriol may have additive effects on bone density. An observational study was…
®(alendronate 5 mg plus calcitriol 0.5 µg) daily or Fosamax Plus ® (alendronate 70 mg plus cholecalciferol 2,800 IU) weekly for 1…
Abstract −Imbalance in calcium and phosphorous metabolism due to aging or menopause leads to osteoporo-sis. In contrast to…
IntroductionA randomized, double-blind, prospective, 24-week clinical trial was performed to evaluate the effects of a…